Page 2 - Strides Pharma Science
Strides Pharma likely to launch affordable insulin from Stelis stable
The Bengaluru-headquartered company believes Stelis could be a disruptor in insulin accessibility and affordability.
 "Strides Pharma likely to launch affordable insulin from Stelis stable")
Strides Pharma resumes sales of antacid drug Ranitidine in Australia
Strides predominantly sells Ranitidine tablets in the US markets
 "Strides Pharma resumes sales of antacid drug Ranitidine in Australia")
Strides Pharma dips 6% after it temporarily suspends Ranitidine sales in US
The stock of pharmaceuticals company was trading lower for the fifth straight day, slipping 14 per cent, as against a 2 per cent rise in the benchmark S&P BSE Sensex during the week.
 "Strides Pharma dips 6% after it temporarily suspends Ranitidine sales in US")
Strides Pharma soars 12% after Co announces JV with Chinese firm
Strides Pharma Global Pte (Singapore) and Sun Moral International (Hong Kong), a wholly-owned subsidiary of Sihuan Pharmaceutical Holdings, have entered into a JV to form called Sihuan Strides.
 "Strides Pharma soars 12% after Co announces JV with Chinese firm")
USFDA finds adulteration, 'significant violations' at Strides Pharma plant
The regulator found 'significant violations' of current good manufacturing practice regulations at Strides Pharma's plant in Puducherry
 "USFDA finds adulteration, 'significant violations' at Strides Pharma plant")
Strides Pharma Puducherry unit receives warning letter from USFDA
The drug firm, however, did not provide any details of the contents of the warning letter received from the regulator.
 "Strides Pharma Puducherry unit receives warning letter from USFDA")
Strides Pharma Science's arm gets USFDA nod to market laxative drug in US
The product will be manufactured at Strides' facility in Bengaluru and will be marketed by Strides Pharma in the US market
